Mortgage rates more closely follow the 10-year U.S. Treasury yield, which doesn’t always align with the direction of Fed fund ...
Kentucky counties with higher primary turnout could strongly influence the 2026 U.S. Senate election. Should campaigns pay ...
The "13" patch on a biker vest (also called a cut) is one of the most recognizable and misunderstood symbols in motorcycle culture. The number represents the 13th position in the alphabet sequence, ...
Google observes its symbolic "birthday" on September 27, distinct from its actual incorporation date. The 2025 celebration revived its original 1998 logo, highlighting its remarkable evolution. The ...
The landmark introduction of the Goods and Services Tax (GST) in 2017 converted India's domestic market, fragmented by multiple regional taxes and border checkpoints, into a single entity. Eight years ...
After a litany of scandals to hit Optus, questions have been asked about how a recent mistake could be made when a process had been put in place to rectify the same mistake in 2023. Optus CEO Stephen ...
George Kyris does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations beyond their ...
Since before the agitation turned violent in Leh on Wednesday, protesters in Ladakh have been protesting for the central government to grant them protections under the Sixth Schedule, as well as the ...
This year's season has been very challenging for airlines and passengers in Europe. Strikes by ground staff, pilots and flight controllers thwarted holiday plans for many travellers and exposed ...
Last Sunday, Prime Minister Mark Carney announced that Canada would recognize Palestinian statehood. In recent weeks, Canada, Australia, Portugal, the U.K. and France have joined the ranks of a ...
Boehringer Ingelheim today announced new data from the global Phase III FIBRONEER™ program on nerandomilast, an investigational oral preferential PDE4B inhibitor, which is currently not approved for ...
Late-stage biopharma Scholar Rock (SRRK) is approaching a pivotal catalyst: the FDA decision on apitegromab, its investigational muscle-targeted therapy for spinal muscular atrophy (SMA). A verdict is ...